Prospectorly
Know what changes as it happens
PubMed alerts and clinical trial update monitoring for the drugs, diseases, and drug–disease pairs you track—then send the changes with the “why” attached.
How it works
Three steps. No hidden process.
You define the alerts. We monitor what’s new. You get email + Watchlist updates with full history.
Track drugs, diseases, and drug–disease pairs—or monitor a specific trial by NCT ID. Each alert has its own cadence.
PubMed and ClinicalTrials.gov are checked on your schedule. New papers, new trials, and trial updates are deduped and recorded.
Get concise updates per alert, plus a watchlist audit trail that shows what changed between runs.
Sample
Try a sample alert.
Clinical Trials
PubMed
Pricing
Transparent pricing, per user.
Seat-based pricing from day one. Organizations get roles and permissions; billing stays per user.
- Email alerts + Watchlist history
- Drugs + diseases + drug–disease pairs
- Per-alert cadence + noise controls (caps + filters)
- Organization roles: owner / admin / editor / viewer
Cancel anytime. Price shown is a placeholder.
Included with every seat
A proof-of-change.
Built for diligence: every match comes with a source link, a timestamped trail, and the exact terms that triggered it—so investors and researchers can act (and cite) fast.
Included sources
- PubMed (new and relevant items)
- ClinicalTrials.gov (new + updated trials)
FAQ
Trust and control, up front.
Investors need a signal they can rely on. Everything is built around coverage, relevance, and an audit trail.
How do you prevent noise?
Caps per alert, with pair alerts for higher precision when you need it.
Can I monitor one specific clinical trial?
Yes—use Trial-specific updates and paste an NCT ID to track ClinicalTrials.gov updates.
Can I change my alerts any time?
Yes—alerts are designed to be edited quickly, without re-onboarding.
Do you support organizations?
Yes—roles and permissions for owners, admins, editors, and viewers.
What does “signal” mean here?
New trials, trial updates, and new papers relevant to your alert.